BASM1_KALSE
ID BASM1_KALSE Reviewed; 763 AA.
AC A0A0S2IHL6;
DT 07-APR-2021, integrated into UniProtKB/Swiss-Prot.
DT 17-FEB-2016, sequence version 1.
DT 25-MAY-2022, entry version 19.
DE RecName: Full=Beta-amyrin synthase 1 {ECO:0000303|PubMed:29186583};
DE Short=KsBAS1 {ECO:0000303|PubMed:29186583};
DE EC=5.4.99.39 {ECO:0000269|PubMed:29186583};
GN Name=BAS1 {ECO:0000303|PubMed:29186583};
GN Synonyms=BAS {ECO:0000303|PubMed:29186583};
OS Kalopanax septemlobus (Castor aralia) (Acanthopanax septemlobus).
OC Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC asterids; campanulids; Apiales; Araliaceae; Kalopanax.
OX NCBI_TaxID=228393;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND CATALYTIC ACTIVITY.
RX PubMed=29186583; DOI=10.1093/pcp/pcx188;
RA Han J.Y., Chun J.H., Oh S.A., Park S.B., Hwang H.S., Lee H., Choi Y.E.;
RT "Transcriptomic analysis of Kalopanax septemlobus and characterization of
RT KsBAS, CYP716A94 and CYP72A397 genes involved in hederagenin saponin
RT biosynthesis.";
RL Plant Cell Physiol. 59:319-330(2018).
CC -!- FUNCTION: Component of the oleanane-type triterpene saponins
CC biosynthetic pathway (PubMed:29186583). Oxidosqualene cyclase
CC converting oxidosqualene into beta-amyrin, generating five rings and
CC eight asymmetric centers in a single transformation (PubMed:29186583).
CC {ECO:0000269|PubMed:29186583}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=(S)-2,3-epoxysqualene = beta-amyrin; Xref=Rhea:RHEA:31007,
CC ChEBI:CHEBI:10352, ChEBI:CHEBI:15441; EC=5.4.99.39;
CC Evidence={ECO:0000269|PubMed:29186583};
CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31008;
CC Evidence={ECO:0000269|PubMed:29186583};
CC -!- PATHWAY: Secondary metabolite biosynthesis; terpenoid biosynthesis.
CC {ECO:0000305}.
CC -!- SIMILARITY: Belongs to the terpene cyclase/mutase family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; KT150523; ALO23119.1; -; mRNA.
DR AlphaFoldDB; A0A0S2IHL6; -.
DR SMR; A0A0S2IHL6; -.
DR UniPathway; UPA00213; -.
DR GO; GO:0005811; C:lipid droplet; IEA:InterPro.
DR GO; GO:0042300; F:beta-amyrin synthase activity; IDA:UniProtKB.
DR GO; GO:0016104; P:triterpenoid biosynthetic process; IDA:UniProtKB.
DR CDD; cd02892; SQCY_1; 1.
DR InterPro; IPR032696; SQ_cyclase_C.
DR InterPro; IPR032697; SQ_cyclase_N.
DR InterPro; IPR018333; Squalene_cyclase.
DR InterPro; IPR002365; Terpene_synthase_CS.
DR InterPro; IPR008930; Terpenoid_cyclase/PrenylTrfase.
DR PANTHER; PTHR11764; PTHR11764; 1.
DR Pfam; PF13243; SQHop_cyclase_C; 1.
DR Pfam; PF13249; SQHop_cyclase_N; 1.
DR SFLD; SFLDG01016; Prenyltransferase_Like_2; 1.
DR SUPFAM; SSF48239; SSF48239; 2.
DR TIGRFAMs; TIGR01787; squalene_cyclas; 1.
DR PROSITE; PS01074; TERPENE_SYNTHASES; 1.
PE 1: Evidence at protein level;
KW Isomerase; Isoprene biosynthesis; Repeat.
FT CHAIN 1..763
FT /note="Beta-amyrin synthase 1"
FT /id="PRO_0000452138"
FT REPEAT 100..142
FT /note="PFTB 1"
FT /evidence="ECO:0000255"
FT REPEAT 150..191
FT /note="PFTB 2"
FT /evidence="ECO:0000255"
FT REPEAT 441..485
FT /note="PFTB 3"
FT /evidence="ECO:0000255"
FT REPEAT 515..560
FT /note="PFTB 4"
FT /evidence="ECO:0000255"
FT REPEAT 592..632
FT /note="PFTB 5"
FT /evidence="ECO:0000255"
FT REPEAT 641..682
FT /note="PFTB 6"
FT /evidence="ECO:0000255"
FT REPEAT 703..744
FT /note="PFTB 7"
FT /evidence="ECO:0000255"
FT ACT_SITE 486
FT /note="Proton donor"
FT /evidence="ECO:0000250|UniProtKB:P48449"
FT SITE 419
FT /note="Transition state stabilizer"
FT /evidence="ECO:0000250|UniProtKB:P48449"
FT SITE 475
FT /note="Transition state stabilizer"
FT /evidence="ECO:0000250|UniProtKB:P48449"
FT SITE 613
FT /note="Transition state stabilizer"
FT /evidence="ECO:0000250|UniProtKB:P48449"
SQ SEQUENCE 763 AA; 87385 MW; BA333A8D580C0ECE CRC64;
MWKLKIAEGD KNDPYLYSTN NFVGRQTWEF DPDYVGSPGE LEEVEEARRQ FGENRYKVKP
CGDLLWRLQF LREKNFKQTI PQVKVGDDEA VTYEAATTTL RRAVHFFSAL QASDGHWPAE
IAGPLYFLPP LVMCLYITGH LDTVFPAEHR KEILRYIYCH QNEDGGWGFH IEGHSTMFCT
TLSYICMRIL GEGPDGGVNN ACARGRKWIL DHGSATAVPS WGKTWLSILG VYEWMGSNPM
PPEFWILPSF LPMHPAKMWC YCRMVYMPMS YLYGKRFVGP ITPLILQLRE ELYAQPYNEI
KWGKVRHVCA KEDIYYPHPL IQDLLWDSLY VLTEPLLTRW PFNKLREKAL QTTMKHVHYE
DENSRYITIG CVEKVLCMLA CWVEDPNGDY FKKHLARIPD YIWVGEDGMK MQSFGSQEWD
TGFGIQALLA SDLTHELGPT LMKGHDFIKK SQVKDNPSGD FKSMYRHISK GSWTFSDQDH
GWQVSDCTAE GLKCCLIFST MPEEIVGKKM EPELLYNSVN ILLSLQSKNG GLAAWEPVTA
QDWLELLNPT EFFADIVIEH EYVECTASAI QALVLFKKLY PGHRKKEIDN FITNAIRFLE
DVQMPDGSWY GNWGVCFTYG SWFALGGLAA AGKTYDNCAA VRKAVNFLLE SQLDDGGWGE
SYLSCPKKVY VPLEGNRSNL VHTGWALMGL IHSGQAERDP TPLHRAAKLL INSQMEDGDF
PQQEITGVFM KNCMLHYATY RNIYPLWALA EYRRRVPLPS LGA